BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20828217)

  • 1. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.
    May D; Pan S; Crispin DA; Lai K; Bronner MP; Hogan J; Hockenbery DM; McIntosh M; Brentnall TA; Chen R
    J Proteome Res; 2011 Jan; 10(1):200-9. PubMed ID: 20828217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and tumor progression in ulcerative colitis.
    Ussakli CH; Ebaee A; Binkley J; Brentnall TA; Emond MJ; Rabinovitch PS; Risques RA
    J Natl Cancer Inst; 2013 Aug; 105(16):1239-48. PubMed ID: 23852949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteins That Underlie Neoplastic Progression of Ulcerative Colitis.
    Brentnall TA; Pan S; Bronner MP; Crispin DA; Mirzaei H; Cooke K; Tamura Y; Nikolskaya T; Jebailey L; Goodlett DR; McIntosh M; Aebersold R; Rabinovitch PS; Chen R
    Proteomics Clin Appl; 2009 Sep; 3(11):1326. PubMed ID: 20098637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced hTERT protein levels are associated with DNA aneuploidy in the colonic mucosa of patients suffering from longstanding ulcerative colitis.
    Friis-Ottessen M; De Angelis PM; Schjølberg AR; Andersen SN; Clausen OP
    Int J Mol Med; 2014 Jun; 33(6):1477-83. PubMed ID: 24676865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis.
    Salk JJ; Bansal A; Lai LA; Crispin DA; Ussakli CH; Horwitz MS; Bronner MP; Brentnall TA; Loeb LA; Rabinovitch PS; Risques RA
    Inflamm Bowel Dis; 2013 Nov; 19(12):2593-602. PubMed ID: 24097228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.
    Bronner MP; O'Sullivan JN; Rabinovitch PS; Crispin DA; Chen L; Emond MJ; Rubin CE; Brentnall TA
    Am J Pathol; 2008 Dec; 173(6):1853-60. PubMed ID: 18988798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia.
    Bista RK; Brentnall TA; Bronner MP; Langmead CJ; Brand RE; Liu Y
    Inflamm Bowel Dis; 2011 Dec; 17(12):2427-35. PubMed ID: 21351200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.
    Risques RA; Lai LA; Himmetoglu C; Ebaee A; Li L; Feng Z; Bronner MP; Al-Lahham B; Kowdley KV; Lindor KD; Rabinovitch PS; Brentnall TA
    Cancer Res; 2011 Mar; 71(5):1669-79. PubMed ID: 21363920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.
    Chen R; Rabinovitch PS; Crispin DA; Emond MJ; Koprowicz KM; Bronner MP; Brentnall TA
    Am J Pathol; 2003 Feb; 162(2):665-72. PubMed ID: 12547724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
    Sjöqvist U; Ost A; Löfberg R
    Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.
    Pekow J; Dougherty U; Huang Y; Gometz E; Nathanson J; Cohen G; Levy S; Kocherginsky M; Venu N; Westerhoff M; Hart J; Noffsinger AE; Hanauer SB; Hurst RD; Fichera A; Joseph LJ; Liu Q; Bissonnette M
    Inflamm Bowel Dis; 2013 Mar; 19(3):461-70. PubMed ID: 23388545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis.
    Fujii S; Katake Y; Tanaka H
    Digestion; 2010; 82(3):179-86. PubMed ID: 20588031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.
    Bronner MP; Skacel M; Crispin DA; Hoff PD; Emond MJ; Lai LA; Tubbs RR; O'Sullivan JN; Rabinovitch PS; Brentnall TA
    Mod Pathol; 2010 Dec; 23(12):1624-33. PubMed ID: 20802465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic mucosal expression of heat-shock proteins may have a potential prognostic value in ulcerative colitis.
    Abou El Azm AR; Yousef M; Kobtan A; Awad A; Elkassas G; Elfert A
    Arab J Gastroenterol; 2015 Mar; 16(1):20-4. PubMed ID: 25797489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
    Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
    Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.